Discuss with your care team, stick to the plan, and schedule a pre-op review to secure timing and safety
According to Lillys trial results, patients who got weekly injections of Zepbound lost an average 20.2% of their body weight, or 50.3 pounds, after 72 weeks, compared with an average of 13.7% body weight, or 33.1 pounds, for those who got Wegovy
The refund process may involve documentation and consultation fees (a 25% fee is noted in policy pages)
However, the Inflation Reduction Act and subsequent CMS guidance opened a narrow door: plans may cover semaglutide when its prescribed for cardiovascular risk reduction in patients who already have established cardiovascular disease
A Critical appraisal of aspirin in secondary prevention